ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

ËïÒÝÏɼÍÄîÒ½ÔºËζûÎÀ½ÌÊÚÍŶÓÑо¿ÂÛÎÄÔÚNature Reviews Drug Discovery½ÒÏþ£º»¯µÐΪÓÑ¡ª¡ª°ÐÏòÖ×ÁöÏà¹Ø³ÉÏËάϸ°û

ÔĶÁÁ¿£º

°©Ö¢±»ÌìÏÂÎÀÉú×éÖ¯ÁÐΪÌìÏÂÎå´óÒÉÄÑÔÓÖ¢Ö®Ò»£¬ £¬Æä·¢²¡ÂÊÒ»Ö±ÔÚÖðÄêÉÏÉý1¡£¡£¡£ËäÈ»½ü50ÄêÀ´¶ÔÐí¶à°©Ö¢ÀàÐÍ¿ªÕ¹µÄ»úÖÆÑо¿ÒѾ­È¡µÃÁ˲»´íµÄÏ£Íû£¬ £¬µ«ÏÖÓеİ©Ö¢ÖÎÁÆģʽÈÔȻδÄÜʵÏÖ¶ÔÖ×ÁöµÄÖÜÈ«¿ØÖÆ¡£¡£¡£Ëæ×ÅPagetÌá³öµÄ¡°ÖÖ×ÓÓëÍÁÈÀ¡±Ñ§Ëµ±»ÆÕ±éÈϿɺÍÑÓÉ죬 £¬Ö×Áö΢ÇéÐÎ×÷Ϊ¡°ÎÖÍÁ¡±Ôö½øÖ×Áö¶ñÐÔÏ£ÍûµÄÒªº¦×÷ÓÃÒÑÔÚ¶àÖÖ°©Ö¢ÖлñµÃ֤ʵ2,3¡£¡£¡£ÒÑÍùÊ®ÄêÖУ¬ £¬¹ØÓÚ¡°Ö×Áö΢ÇéÐÎÓëÖ×Áöϸ°ûÏ໥×÷Óá¢ÅäºÏ½ø»¯¡±µÄ´ó×Ú֪ʶ´Ùʹ¿Æѧ¼ÒÃÇÑо¿Ò»ÖÖÐÂÐÍ°©Ö¢ÖÎÁÆ·¶Ê½¡ª¡ª°ÐÏòÖ×ÁöÍÁÈÀ¡£¡£¡£È»¶ø£¬ £¬Ö×Áö΢ÇéÐÎÒòËØÖØ´ó£¬ £¬¾ßÓи߶ȵÄÒìÖÊÐÔ¡£¡£¡£ÔõÑù׼ȷɸѡ°Ð±êÓ¦ÓÃÓÚÖ×Áö°ÐÏòÖÎÁÆÊÇ»ù´¡»·½Ú£¬ £¬Ò²ÊÇÒªº¦·½·¨¡£¡£¡£

Ö×ÁöÏà¹Ø³ÉÏËάϸ°û(CAFs)ͨ³£ÊÇÖ×Áö΢ÇéÐÎÖÐ×ºñµÄ¼äÖÊϸ°û£¬ £¬ÔÚÖ×ÁöÏ£ÍûÀú³ÌÆð×ÅÖ÷ÒªµÄ×÷Óᣡ£¡£ÕâÌáÐÑCAFs¿ÉÄܳÉΪ¶ñÐÔÖ×ÁöÖÎÁƵÄÀíÏë°Ðµã¡£¡£¡£2018Äê11ÔÂ23ÈÕ£¬ £¬ngµç×ÓÓÎÏ·ËïÒÝÏɼÍÄîÒ½ÔºËζûÎÀ½ÌÊÚÍŶÓÔÚNature Reviews Drug Discovery£¨IF=50.17£©ÔÚÏß½ÒÏþÁËÌâΪ¡°Turning foes to friends: targeting cancer-associated fibroblasts¡±µÄ×ÛÊöÎÄÕÂ4¡£¡£¡£ËζûÎÀ½ÌÊÚΪͨѶ×÷Õߣ¬ £¬³ÂÑ©Âü²©Ê¿ÎªµÚÒ»×÷Õß¡£¡£¡£¸ÃÂÛÎÄϵͳ×ܽáÁËÏÖÓÐCAFsÑо¿µÄÏ£Íû£¬ £¬ÖصãÌÖÂÛÁË°ÐÏò»òʹÓÃCAFs¾ÙÐа©Ö¢ÖÎÁƵÄDZÔÚÕ½ÂÔ£¬ £¬ÒÔ¼°¸ÃÁÆ·¨Ó¦ÓÃÓÚÁÙ´²±£´æµÄÌôÕ½£¬ £¬¶Ô¿ªÕ¹¡°Í¨¹ý°ÐÏòÒÔCAFsΪÖ÷ÌåµÄÖ×ÁöÍÁÈÀÖÎÁÆ°©Ö¢¡±ÕâÒ»ÐÂÐÍÁÆ·¨¾ßÓÐÔö½øÒâÒå¡£¡£¡£

Ê×Ò³|ngµç×ÓÓÎÏ·Öйú¼¯ÍŹٷ½ÍøÕ¾

ËζûÎÀ½ÌÊÚÍŶӺã¾ÃÖÂÁ¦ÓÚÖ×Áö΢ÇéÐÎÔö½øÖ×Áö¶ñÐÔÏ£ÍûµÄ»úÖÆÑо¿¡£¡£¡£¿£¿ÎÌâ×éÇ°ÆÚ¶ÔÈéÏÙ°©»¼Õßи¨Öú»¯ÁÆÇ°ºóµÄÖ×Áö±ê±¾¾ÙÐÐÑо¿£¬ £¬Ê×´Îͨ¹ý¸ßͨÁ¿É¸Ñ¡µÄĤÂÑ°×£¨CD10ºÍGPR77£©ÅжÏÁËÒ»ÖÖÔÚÖ×Áö΢ÇéÐθ»¼¯µÄ³ÉÏËάϸ°ûÑÇȺ5¡£¡£¡£ÕâȺCD10+GPR77+ CAFsÄܹ»Î¬³ÖÖ×Áö¸Éϸ°ûµÄÌØÕ÷£¬ £¬ÒýÆðÖ×Áö»¯ÁÆÄÍÊÜ¡£¡£¡£¸üÖ÷ÒªµÄÊÇ£¬ £¬°ÐÏòGPR77ÏÔÖøïÔÌ­ÁËÕâȺCAFsºÍÖ×Áö¸Éϸ°ûµÄÊýÄ¿£¬ £¬Ìá¸ßÁËÖ×Áö»¯ÁƵÄÃô¸ÐÐÔ£¬ £¬ÌáÐÑ°ÐÏòCAFs¾ßÓÐÓÅÒìµÄÖÎÁƼÛÖµ¡£¡£¡£

Ê×Ò³|ngµç×ÓÓÎÏ·Öйú¼¯ÍŹٷ½ÍøÕ¾

ΪÁË×ÊÖúCAFsµÄ¹¦Ð§ÒâÒåºÍ·Ö×Ó»úÖƱ»»ù´¡Ñо¿ºÍÐÂÒ©Ñз¢ÕßÃǽøÒ»²½ÊìϤºÍ¸üÖÜÈ«µØÏàʶ£¬ £¬±¾ÎĶÔCAFsµÄÉúÎïѧÌØÕ÷¡¢Ï¸°ûÆðÔ´¡¢±íÐÍ¿ÉËÜÐԺ͹¦Ð§ÒìÖÊÐÔ¾ÙÐÐÁËϵͳµÄ×ܽᣬ £¬ÉîÈëÐðÊöÁËCAFsÓëÖ×Áöϸ°ûºÍÆäËû¼äÖÊϸ°ûÖ®¼äµÄÏ໥×÷Ó㬠£¬²¢ÒÔºÎÖÖ½ÇÉ«¼ÓÈëÖ×Áö±¬·¢¡¢¿ªÕ¹¡¢×ªÒƺÍÄÍÒ©µÈÀú³Ì£¬ £¬ÖصãÌÖÂÛÁËÔõÑù°ÐÏò»òʹÓÃÕâЩϸ°û¾ÙÐа©Ö¢µÄÖÎÁÆ£¬ £¬ÒÔ¼°CAFs°ÐÏòÁÆ·¨ÒýÈëÁÙ´²±£´æµÄÎÊÌâºÍÌôÕ½¡£¡£¡£ËζûÎÀ½ÌÊÚÍŶÓÊ×´Îϵͳ×ÛÊöÁË°ÐÏòCAFsË¢ÐÂÖ×Áö΢ÇéÐÎÒÔÖÎÁÆ°©Ö¢µÄÑо¿Ï£Íû£¬ £¬¶Ô¼ÓËÙCAFsÕâÒ»ÁìÓò´Ó»ù´¡Ñо¿¹âÁÙ´²Êµ¼ùµÄת»¯ÓÐ×ÅÖ÷ÒªµÄÒâÒå¡£¡£¡£

ÂÛÎÄÁ´½Ó£ºwww.nature.com/articles/s41573-018-0004-1

²Î¿¼ÎÄÏ×£º

1. Torre, L.A., et al. Global cancer statistics, 2012. CA: a cancer journal for clinicians65, 87-108 (2015).

2. Paget, S. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. The Lancet133, 571-573 (1889).

3. Langley, R.R. & Fidler, I.J. The seed and soil hypothesis revisited¡ªThe role of tumor©\stroma interactions in metastasis to different organs. International journal of cancer128, 2527-2535 (2011).

4. Chen, X. & Song, E. Turning foes to friends: targeting cancer-associated fibroblasts. Nature Reviews Drug Discovery (2018).

5. Su, S., et al. CD10(+)GPR77(+) Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness. Cell (2018).

¡¾ÍøÕ¾µØͼ¡¿